MEF2D and cancer: In Treg cells, Mef2d is required to sustain and integrate the Foxp3 transcriptional repertoire (18); Mef2d deletion in Foxp3+ cells impairs the acquisition of an eTreg phenotype and leads to an increase in anti-cancer immunity and transplant rejection (18).